<DOC>
	<DOCNO>NCT01371474</DOCNO>
	<brief_summary>The objective survey understand safety efficacy PAXIL tablet ( `` PAXIL '' , hereinafter ) start 20 mg/day subject depression depress state .</brief_summary>
	<brief_title>Special Drug Use Investigation PAXIL Tablet ( Investigation Case Administered From 20mg/Day )</brief_title>
	<detailed_description />
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Patients depression depress state Patients start take paroxetine 20mg day Patients treat paroxetine prior investigation Patients hypersensitivity paroxetine Patients take monoamine oxidase inhibitor ( MAOIs ) within 2 week stop treatment MAOIs Concomitant use patient take pimozide</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>